Stock Events

Stock Events

SIGA Technologies 

$3.12
273
-$0.27-8.11% 19:06 Today

Statistics

Day High
3.37
Day Low
3.1
52W High
9.62
52W Low
3.1
Volume
636,576
Avg. Volume
534,508
Mkt Cap
223.42M
P/E Ratio
12.82
Dividend Yield
17.7%
Dividend
0.55

Upcoming

7
APR 27
Dividend Ex
Estimated
 
23
APR 27
Dividend Payment
Estimated
 
7
APR 28
Dividend Ex
Estimated
 
21
APR 28
Dividend Payment
Estimated
 

Dividends

17.7%Dividend Yield
Apr 26
$0.60
May 25
$0.60
Apr 24
$0.60
Jun 23
$0.45
Jun 22
$0.45
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
10.06%
1Y Growth
N/A

Earnings

30JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.09
0.15
0.39
0.63
Expected EPS
N/A
Actual EPS
N/A

Financials

24.61%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
94.58MRevenue
23.28MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SIGA. It's not an investment recommendation.
Microsoft
34
MSFT
Apple
33
AAPL
Realty Income
31
O
AGNC Investment
31
AGNC

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences is a major player in the antiviral drug market, offering a range of products that compete with SIGA's portfolio.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.43B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals, potentially competing in the same therapeutic areas as SIGA.
Pfizer
PFE
Mkt Cap137.76B
Pfizer Inc, with its broad range of vaccines and antiviral drugs, competes in the same market as SIGA Technologies.
Moderna
MRNA
Mkt Cap27.09B
Moderna Inc is known for its mRNA technology used in vaccines, which could compete with SIGA's treatments in the infectious disease space.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its pharmaceutical division, develops treatments that could compete with SIGA's antiviral and vaccine products.
Novavax
NVAX
Mkt Cap1.53B
Novavax, Inc. focuses on developing vaccines, including for viral infections, which places it in direct competition with SIGA.
Arbutus Biopharma
ABUS
Mkt Cap948.18M
Arbutus Biopharma Corporation works on antiviral therapies and delivery technologies, competing with SIGA in the antiviral space.
Inovio Pharmaceuticals
INO
Mkt Cap97.08M
Inovio Pharmaceuticals, Inc. specializes in DNA medicines, including vaccines for infectious diseases, competing with SIGA's offerings.
Vir Biotechnology
VIR
Mkt Cap1.68B
Vir Biotechnology, Inc. focuses on treating and preventing serious infectious diseases, directly competing with SIGA Technologies in the antiviral market.

About

SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
Show more...
CEO
Dr. Diem Nguyen M.B.A., Ph.D.
Employees
46
Country
United States
ISIN
US8269171067

Listings

XNAS
US
SIGA
BOATS
BOATS
SIGA.BOATS

0 Comments

Share your thoughts

FAQ

What is SIGA Technologies stock price today?▼
The current price of SIGA is $3.12 USD — it has decreased by -8.11% in the past 24 hours. Watch SIGA Technologies stock price performance more closely on the chart.
What is SIGA Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange SIGA Technologies stocks are traded under the ticker SIGA.
Is SIGA Technologies stock price growing?▼
SIGA stock has fallen by -12.5% compared to the previous week, the month change is a -27.56% fall, over the last year SIGA Technologies has showed a -56.49% decrease.
What is SIGA Technologies market cap?▼
Today SIGA Technologies has the market capitalization of 223.42M
When is the next SIGA Technologies earnings date?▼
SIGA Technologies is going to release the next earnings report on July 30, 2026.
What were SIGA Technologies earnings last quarter?▼
SIGA earnings for the last quarter are -0.05 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SIGA Technologies revenue for the last year?▼
SIGA Technologies revenue for the last year amounts to 94.58M USD.
What is SIGA Technologies net income for the last year?▼
SIGA net income for the last year is 23.28M USD.
Does SIGA Technologies pay dividends?▼
Yes, SIGA dividends are paid annual. The last dividend per share was 0.6 USD. As of today, Dividend Yield (FWD)% is 17.7%.
How many employees does SIGA Technologies have?▼
As of July 23, 2026, the company has 46 employees.
In which sector is SIGA Technologies located?▼
SIGA Technologies operates in the Health & Wellness sector.
When did SIGA Technologies complete a stock split?▼
SIGA Technologies has not had any recent stock splits.
Where is SIGA Technologies headquartered?▼
SIGA Technologies is headquartered in New York, United States.